title: UIP 2011 C3 consensus.
authors.forename: A
authors.initials: A
authors.lastname: Cornu Thenard
authors.forename: A
authors.initials: A
authors.lastname: Scuderi
authors.forename: A A
authors.initials: AA
authors.lastname: Ramelet
authors.forename: B
authors.initials: B
authors.lastname: Eklöf
authors.forename: M
authors.initials: M
authors.lastname: Flour
authors.forename: K
authors.initials: K
authors.lastname: Delis
authors.forename: F
authors.initials: F
authors.lastname: Padberg
authors.forename: M
authors.initials: M
authors.lastname: Jünger
authors.forename: G M
authors.initials: GM
authors.lastname: Malouf
mesh_terms: D002908:Chronic Disease; D003937:Diagnosis, Differential; D004487:Edema / Q000145:classification* / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006496:Heparinoids / Q000008:administration & dosage; D006801:Humans; D048228:Intermittent Pneumatic Compression Devices; D011237:Predictive Value of Tests; D012307:Risk Factors; D012720:Severity of Illness Index; D009626:Terminology as Topic; D014652:Vascular Diseases / Q000145:classification* / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology / Q000628:therapy; D014680:Veins / Q000187:drug effects / Q000473:pathology
chemical_list: D006496:Heparinoids